Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

In a Market Yet to Bottom, I Like Deep Value Stocks and This Defense Sector

I still believe equities have another leg down before we find a bottom.

The Fed Now Has More Incentive for an Aggressive Series of Rate Hikes

Chances for a 'soft landing' lessen by the week.

2 Small-Cap Stocks That Insiders Are Buying

The moves come as stocks feel like they are at an inflection point after deep losses in the first half of 2022.

Here's How Rocket Can Fuel Your Portfolio

As mortgage rates fly higher, this options play in RKT could take off.

Have Investors Seen the Worst of These Markets?

Second quarter earnings begin next week and all eyes will be on profit margins.

Don't Ignore These 2 Stocks Deep in Bargain Territory

I remain on a cautious stance and still believe equities have not found a true bottom, but that doesn't mean I'm completely on the sidelines.

This Energy Play Should Turn Out A-'OKE'

Let's learn how to make an enhanced yield trade in Oneok.

Let's Size Up the Market's Prospects for the Second Half of 2022

The next six months can't be worse than the first six, can they?

As Biotechs Seem to Have Bottomed, Here Are 3 to Consider

I expect biotech M&A activity to pick up in the back half of 2022.

Here's Why I've Been Accumulating Homebuilder Stocks

There has been a lack of overbuilding in the housing market and inventories remain low.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight